Checkpoint Therapeutics I...

NASDAQ: CKPT · Real-Time Price · USD
4.26
0.00 (0.00%)
At close: May 29, 2025, 3:59 PM

Checkpoint Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.6M 4.93M 12.07M 54.73M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a 73K 17K
Inventory
n/a n/a n/a n/a
Other Current Assets
867K 450K 1.15M n/a
Total Current Assets
7.47M 5.38M 13.29M 55.73M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a
Total Assets
7.47M 5.38M 13.29M 55.73M
Account Payables
6.09M 6.57M 11.54M 16.14M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
11.57M 1.33M 11.45M 233K
Total Current Liabilities
20.1M 18.43M 32.77M 25.98M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 20.3M n/a
Total Liabilities
20.1M 18.43M 32.77M 25.98M
Total Debt
n/a n/a n/a n/a
Common Stock
5K 3K 1K 1K
Retained Earnings
-370.57M -314.33M -262.49M -199.86M
Comprehensive Income
n/a 3.42M 1.89M 6.6M
Shareholders Equity
-12.63M -13.05M -19.48M 29.75M
Total Investments
n/a n/a n/a n/a